Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Paxlovid
Paxlovid
Here's Why Pfizer's COVID Revenue Could Remain Strong Next Year
Motley Fool
Wed, 06/1/22 - 07:33 pm
Pfizer
COVID-19
vaccines
Paxlovid
CDC warns of rebounding symptoms after Paxlovid
Beckers Hospital Review
Thu, 05/26/22 - 10:11 am
Pfizer
Paxlovid
CDC
antivirals
COVID-19
US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf
Endpoints
Wed, 05/25/22 - 11:47 pm
Pfizer
HHS
Paxlovid
Merck
molnupiravir
AstraZeneca
Evusheld
COVID-19
As reports of ‘Paxlovid rebound’ increase, Covid researchers scramble for answers
Stat
Tue, 05/24/22 - 10:39 am
COVID-19
Pfizer
Paxlovid
NIH in talks with Pfizer to study a longer course of COVID drug Paxlovid, Fauci says
Fierce Pharma
Thu, 05/19/22 - 12:03 am
Pfizer
Paxlovid
COVID-19
NIH
Why Pfizer May Be Holding Paxlovid Close to the Chest
BioSpace
Wed, 05/18/22 - 11:54 pm
Pfizer
Paxlovid
COVID-19
antivirals
Pfizer's Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned?
Motley Fool
Wed, 05/18/22 - 10:26 am
Pfizer
COVID-19
Paxlovid
Is Paxlovid, the Covid pill, reaching those who most need it? The government won’t say
Endpoints
Thu, 05/12/22 - 10:19 am
Pfizer
Paxlovid
COVID-19
ICER says Pfizer's Paxlovid, Merck's molnupiravir both cost effective, but their benefits are far from equal
Fierce Pharma
Tue, 05/10/22 - 10:50 am
ICER
Pfizer
Paxlovid
Merck
Ridgeback Biotherapeutics
molnupiravir
COVID-19
Pfizer Is Poised to Shatter These 2 Records in 2022
Motley Fool
Thu, 05/5/22 - 10:41 am
Pfizer
earnings
Paxlovid
FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return
Fierce Pharma
Wed, 05/4/22 - 05:46 pm
Pfizer
Albert Bourla
Pharma CEOs
FDA
Paxlovid
COVID-19
Pfizer cuts 2022 earnings outlook despite strong first-quarter Covid vaccine and antiviral sales
CNBC
Tue, 05/3/22 - 10:34 pm
Pfizer
earnings
COVID-19
vaccines
Paxlovid
Paxlovid's post-exposure protection flop hardly spells the end for Pfizer's COVID franchise: analysts
Fierce Pharma
Mon, 05/2/22 - 11:54 am
Pfizer
Paxlovid
COVID-19
antivirals
clinical trials
How Paxlovid came to be: From the germ of an idea to a vital tool against Covid
Stat
Thu, 04/28/22 - 10:47 am
Paxlovid
Pfizer
antivirals
COVID-19
Biden administration starts Covid treatment push, focusing on Pfizer’s Paxlovid
Stat
Tue, 04/26/22 - 10:07 am
Joe Biden
antivirals
Paxlovid
Pfizer
COVID-19
Anti-Covid Pill Coming To All U.S. Pharmacies Under Reported Biden Plan
Forbes
Sat, 04/23/22 - 04:11 pm
Joe Biden
Paxlovid
COVID-19
antivirals
'Betrayal of public trust': Pfizer under fire for resisting Paxlovid compulsory license
Fierce Pharma
Thu, 04/21/22 - 11:18 pm
Pfizer
Paxlovid
COVID-19
patient advocacy groups
Could Pfizer's Paxlovid or other antivirals help cure long COVID?
Fierce Pharma
Mon, 04/18/22 - 10:46 am
Pfizer
Paxlovid
Long COVID
COVID-19
antivirals
High-flying Pfizer may disappoint on Comirnaty and Paxlovid sales in Q1, analyst warns
Fierce Pharma
Mon, 04/11/22 - 07:32 pm
Pfizer
BioNTech
Paxlovid
Comirnaty
vaccines
COVID-19
earnings
'March-in' battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision
Endpoints
Mon, 03/28/22 - 10:08 am
HHS
Bayh-Dole Act
drug pricing
Pfizer
Gilead Sciences
Xtandi
Paxlovid
Epclusa
Descovy
insulin
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »